Trials / Completed
CompletedNCT01875484
Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling
Impact of Circulating miR-126 on Left Ventricular Remodeling and Clinical Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention. The PMIR-miR-126 Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (actual)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Purpose: The purpose of this study is to evaluate the impact of circulating miR-126 on left ventricular remodeling and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Conditions
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2015-06-01
- Completion
- 2015-07-01
- First posted
- 2013-06-11
- Last updated
- 2015-07-30
Locations
17 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01875484. Inclusion in this directory is not an endorsement.